Ginkgo Bioworks
DNA
DNA
165 hedge funds and large institutions have $183M invested in Ginkgo Bioworks in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.75% less ownership
Funds ownership: 71.91% → 71.16% (-0.75%)
43% less capital invested
Capital invested by funds: $319M → $183M (-$136M)
Holders
165
Holding in Top 10
3
Calls
$5.98M
Puts
$3.75M
Top Buyers
| 1 | +$5.19M | |
| 2 | +$4.32M | |
| 3 | +$3.23M | |
| 4 |
JMFC
J.M. Forbes & Co
Boston,
Massachusetts
|
+$2.24M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$1.51M |
Top Sellers
| 1 | -$15.7M | |
| 2 | -$5.37M | |
| 3 | -$2.72M | |
| 4 |
Walleye Capital
New York
|
-$2.61M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.33M |
